IMDYLLTRA

Serial Number 98131173
606

Registration Progress

Application Filed
Aug 14, 2023
Under Examination
Jun 18, 2024
Approved for Publication
Apr 23, 2024
Published for Opposition
Apr 23, 2024
Registered

Trademark Image

IMDYLLTRA

Basic Information

Serial Number
98131173
Filing Date
August 14, 2023
Published for Opposition
April 23, 2024
Abandonment Date
July 21, 2025
Drawing Code
4

Status Summary

Current Status
Inactive
Status Code
606
Status Date
Jul 21, 2025
Classes
005

Rights Holder

Amgen Inc.

03
Address
One Amgen Center Drive
Trademark Operations MS-28-5A
Thousand Oaks, CA 91320-1799

Ownership History

Amgen Inc.

Original Applicant
03
Thousand Oaks, CA

Amgen Inc.

Owner at Publication
03
Thousand Oaks, CA

Legal Representation

Attorney
Elsa D. Lemoine

USPTO Deadlines

All Deadlines Cleared

All 2 deadline(s) have been cleared by subsequent events. No active deadlines at this time.

Application History

14 events
Date Code Type Description Documents
Jul 21, 2025 MAB6 E ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED Loading...
Jul 21, 2025 ABN6 S ABANDONMENT - NO USE STATEMENT FILED Loading...
Mar 3, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Nov 26, 2024 EX1G S SOU EXTENSION 1 GRANTED Loading...
Nov 25, 2024 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Nov 25, 2024 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 18, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Apr 23, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Apr 23, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Apr 3, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Mar 21, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Mar 21, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Sep 12, 2023 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Aug 17, 2023 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
Pharmaceutical preparations used for the treatment of cancer; pharmaceutical preparations used for the treatment of lung, prostate and respiratory disorders

Classification

International Classes
005